TL
Tilray Brands, Inc.
TLRY · NASDAQ
$4.50 -0.22% (-$0.01)
1M -1.53%
Market Cap $506.6M
P/E Ratio -
Div. Yield -
ROE 7.95%
Piotroski F-Score Weak
3/9Valuation
44 /100
Fair EV/EBITDA 41.88x
P/B 0.31x
P/S 0.44x
Growth
26 /100
Declining Rev. growth 2.72%
Book val. growth 28.77%
EPS growth N/A
Profitability
10 /100
Weak Gross margin 27.57%
FCF margin 9.87%
Net margin 12.90%
Quality
6 /100
Poor ROIC 3.46%
Asset turnover 0.50x
ROE 7.95%
Debt
45 /100
Moderate Debt/Equity 0.25x
Net debt/EBITDA 10.63x
Current ratio 2.21x
Stability
15 /100
Unstable Beta 1.92x
Profitable years 0
Rev. volatility 23.02%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TLRY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
3,595
Headquarters
Leamington
Nadcházející události
08 ŘÍJ
Earnings
Upcoming earnings report